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Transcriptional repression and DNA looping associated
with a novel regulatory element in the final exon
of the lymphotoxin-b gene
K Wicks and JC Knight
Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK
Transcriptional regulation has a critical role in the coordinate and context-specific expression of a cluster of genes encoding
members of the tumour necrosis factor (TNF) superfamily found at chromosome 6p21, comprising TNF, LTA (encoding
lymphotoxin-a) and LTB (encoding lymphotoxin-b). This is important, as dysregulated expression of these genes is implicated
in susceptibility to many autoimmune, inflammatory and infectious diseases. We describe here a novel regulatory element in
the fourth exon of LTB, which is highly conserved, localises to the only CpG island in the locus, and is associated with a DNase
I hypersensitive site and specific histone modifications. We find evidence of binding by Yin Yang 1 (YY1), cyclic AMP response
element (CRE)-binding protein (CREB) and CCCTC-binding factor (CTCF) to this region in Jurkat T cells, which is associated
with transcriptional repression on reporter gene analysis. Chromatin conformation capture experiments show evidence of DNA
looping, involving interaction of this element with the LTB promoter, LTA promoter and TNF 30 untranslated region (UTR). Small
interfering RNA (siRNA) experiments demonstrate a functional role for YY1 and CREB in LTB expression. Our findings provide
evidence of additional complexity in the transcriptional regulation of LTB with implications for coordinate expression of genes in
this important genomic locus.
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Introduction
The tumour necrosis factor (TNF) superfamily has a
critical role in immunity and the inflammatory response,
with dysregulation of these proteins and associated
signalling pathways implicated in the pathogenesis of
a number of important autoimmune, infectious and
inflammatory diseases. Three key members of the
superfamily are encoded by tandemly arranged genes
found in a short region of the major histocompatibility
complex (MHC) on chromosome 6p21: TNF (encoding
tumour necrosis factor), LTA (encoding lymphotoxin a,
LTa) and LTB (encoding lymphotoxin-b,L T b). Expres-
sion of these genes is tightly regulated, notably at a
transcriptional level, with evidence of stimulus and cell-
type specificity in regulation of the TNF gene involving
promoter and 30 untranslated region (UTR) elements.
1–4
Recently, we highlighted a number of putative regulatory
elements lying outside the promoter regions of these
genes based on chromatin profiling for DNase accessi-
bility and histone modifications. These included an
intergenic site located at 3.5kb upstream of LTA,
5 which
is also found in mice.
6 Our analysis demonstrated that
the sequence spanning the final exon of LTB showed
evidence of DNase I hypersensitivity and acetylation of
histones H3 and H4, together with trimethylated K4 of
histone H3, raising the hypothesis that the final exon of
LTB contains a regulatory element that has a role in the
transcriptional regulation of LTB or neighbouring genes
in the TNF cluster.
5
Studies to date characterising the regulation of LTB
gene expression have defined an inducible core promo-
ter, with evidence of a role for a number of transcription
factors, including nuclear factor kB (NFkB), Ets, Egr-1
and Sp1.
7–9 The regulation of LTB is physiologically
important, as increasing numbers of studies highlight the
biological significance of LTb, and of the LTb receptor to
which it binds as a heterodimer with LTa.
10–14 During
embryogenesis, mouse studies have shown a critical role
for LTb in the development of lymphoid organs, and LTb
continues to have an important function in these tissues
during adult life. The role of LTab is, however,
recognised to be much more extensive involving recruit-
ment and activation of diverse cell types, including
lymphocytes and T cells. High levels of LTb are noted in
lymph nodes, and specific cell types such as CD4þ
T cells from patients with chronic inflammatory condi-
tions, such as tuberculosis and inflammatory bowel
disease.
15,16
Cells of lymphoid lineage, including T-, B-, natural
killer cells and lymphoid tissue-inducer cells are im-
portant sources of LTb.
17 Jurkat T cells have been widely
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of LTB, with strong inducibility on stimulation with the
phorbol ester phorbol 12-myristate 13-acetate (PMA) and
ionomycin.
5,7,8,18 Here, we characterise a putative reg-
ulatory region within the final exon of the LTB gene and
show evidence of recruitment of Yin Yang 1 (YY1), cyclic
AMP response element (CRE)-binding protein (CREB)
and CCCTC-binding factor (CTCF) with important
consequences for transcriptional activity and interactions
involving LTB and other genes in the TNF locus.
Results
A DNase I hypersensitive site with features of a regulatory
element
We have previously identified a DNase I hypersensitive
site in LTB, DHS 56700, which was present in a variety of
cell types, including Jurkat T cells, and localises to the
only significant CpG island in the TNF locus.
5 We
extended this analysis using ChIP-chip and ChIP-seq
data from the Duke/UNC/UT-Austin/EBI ENCODE
analysis for DNase I to confirm striking DNase hyper-
sensitivity in the fourth exon of LTB (Figure 1). Analysis
of nucleosome accessibility by formaldehyde-assisted
isolation of regulatory elements was also consistent with
this (Figure 1), highlighting the region’s potential
regulatory significance. We had previously shown that
the site has marked enrichment of histone acetylation
(H3 and H4) together with a peak of trimethylated lysine
4 of histone H3 in Jurkat T cells.
5 We investigated
whether these epigenetic marks were present in other
cell types using ChIP-seq data from the Broad Institute as
part of the ENCODE Histone Modifications analysis
data set. This supported the results we had observed in
Jurkat T cells (Figure 1). We also investigated sequence
conservation at this site among vertebrates based on
analysis of 44 species (Vertebrate Multiz Alignment &
Conservation) using the UCSC Genome Browser data-
base.
19,20 Analysis of PhastCons conserved elements using
a conservative threshold, highlighting two regions
showing a logarithm of the odds ratio (LOD) 4100
(Figure 1). One of these falls in the LTB promoter region
(chr6: 31658240–31658359) (score 555, LOD 197), the
other localises to exon 4 of LTB (chr6: 31656508–3165
6599) (score 521, LOD 146).
Complex protein–DNA interactions involving CREB and YY1
In view of these data, we sought to investigate further
the regulatory significance of this region, considering
first potential protein–DNA interactions in the region of
DHS 56700 using Jurkat T cells as a model system. We
carried out systematic in vitro solid-phase DNase I
footprinting studies over exon 4 of LTB and flanking
sequences (chr6: 31656372–31657330) using nuclear ex-
tracts prepared from Jurkat T cells, either resting or
following stimulation with PMA and ionomycin. This
showed evidence of a number of sites of protein–DNA
interactions with four regions of protection noted
(denoted LTB1–4) (Figure 2). To complement these data,
we carried out an in silico analysis of putative transcrip-
tion factor binding sites using the JASPAR database
combined with cross-species comparison to establish
phylogenetic footprints using the ConSite algorithm.
21–23
This highlighted a potential CREB binding site within the
first DNase I footprint LTB1 at chr6: 31656531–31656542
together with a consensus binding site for YY1 at chr6:
31656514–31656519 (Figure 2). Within the second DNase I
footprint LTB2, we noted a potential NFkB (REL) binding
site at chr6: 31656743–31656753, although this sequence
was not conserved in the mouse. No other in silico-
predicted transcription factor binding sites corresponded
to our experimentally derived DNase I footprinting data
for Jurkat T cells.
We proceeded to analyse the regions highlighted by
DNase I footprinting using electrophoretic mobility shift
assays (EMSAs). A radiolabelled probe spanning the
region of protection LTB1 showed strong constitutive
binding of at least two protein–DNA complexes, which
appeared specific on competition with molar excess of
shorter unlabelled probes corresponding to the putative
transcription factor binding sites for CREB and YY1
(Figure 3). Complexes I and II show a supershift effect on
incubation with anti-CREB and with anti-YY1 antibodies,
respectively, consistent with CREB and YY1 binding
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Figure 1 Overview of chromatin accessibility, histone modifica-
tions and sequence conservation at LTB. A 2.7kb region spanning
LTB (chr6: 31655900–31658600) is shown with the location of a CpG
island (count 75) indicated. Data for Jurkat T cells show the site of
DHS 56700 and histone modifications based on chromatin im-
munoprecipitation using antibodies to diacetylated histone H3
(H3Ac), tetracetylated histone H4 (H4Ac) and trimethylated histone
K4 H3 (H3K4Me3) quantified by real-time quantitative PCR, with
enrichment relative to input DNA displayed.
5 Data from the
Duke/UNC/UT-Austin/EBI ENCODE group for DNase I (based
on DNase-seq and DNase-chip) and formaldehyde assisted isola-
tion of regulatory elements (FAIRE)
52 are shown for the lympho-
blastoid cell line GM12878 and chronic myelogenous leukaemia cell
line K-562 downloaded from the UCSC Browser. ChIP-seq data for
H3K27Ac is shown for K562 cells using data generated by the Broad
Institute as part of the ENCODE Histone Modifications analysis.
Sequence conservation based on Vertebrate Multiz Alignment
and Conservation analysis of 44 species is shown together with
conserved elements based on PhastCons for placental mammal
species.
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Figure 2 Solid-phase DNase I footprinting of putative regulatory element at LTB exon 4 using no nuclear extract (lanes 2–4) or nuclear
extract prepared from unstimulated Jurkat T cells (J) (lane 5) or cells stimulated with PMA/ionomycin for times indicated (K) (lane 6–7).
Regions of protection are indicated by open boxes, increased DNase sensitivity by arrows with nucleotide position based on a Maxam–Gilbert
sequencing ladder (lane 1). (a) Footprinting analysis chr6: 31656372–31656725 showed protection at chr6: 31656512–31656542 denoted LTB1.
(b) Footprinting analysis chr6: 31656634–31656999 demonstrated protection at chr6: 31656745–31656765 (LTB2); chr6: 31656782–31656788
(LTB3); and chr6: 31656920–31656940 (LTB4) with increased DNase sensitivity at chr6: 31656915 flanking this latter region of protection.
(c) DNA sequence spanning exon 4 of LTB showing human-mouse alignment, summarising results of DNase I footprinting experiments
and putative transcription factor binding sites. DNA sequences for human (hg18) (March 2006 NCBI Build 36.1) chr6: 31656436–31656971
and mouse (mm9) (July 2007 Build 37) chr17: 35332577–353333140 aligned using the CLUSTAL W (version 1.81).
53 Coding sequence
corresponding to exon 4 is shown in bold with footprinted regions indicated by black boxes. Putative transcription factor binding sites are
indicated by sequence logos incorporating data from JASPAR nucleotide frequency matrix.
22,54
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Genes and Immunity(Figure 3). These results were also seen on competition
and supershift EMSA experiments using shorter radi-
olabelled probes containing each site individually (data
not shown). We then performed chromatin immunopre-
cipitation assays in Jurkat T cells to investigate whether
these protein–DNA interactions were occurring in vivo.
This confirmed that YY1 and CREB bind to this region in
the absence of stimulation and that binding increases
during mitogen stimulation (Figure 3). The second
region showing protection on DNase I footprinting
(LTB2) contained a potential NFkB-binding site but
chromatin immunoprecipitation experiments failed to
demonstrate binding by p50 or p65 in vivo (data not
shown). The other two footprinted regions LTB3 and
LTB4 did show evidence of specific protein–DNA
interactions on EMSA (data not shown), however, the
identity of the proteins involved in these complexes
remains to be defined.
DNA looping involving LTB exon 4, the LTB and LTA
promoter, and TNF 30 UTR
The location of the putative LTB regulatory element
within the final exon of the gene is relatively unusual,
and it was unclear whether any regulatory effects were
specific to LTB or of more global significance. This
promoted us to investigate whether this sequence
showed evidence of interaction with other sites in the
TNF locus. We used a chromatin conformation capture
technique
24 to test this hypothesis for a 48kb region
encompassing NFKBIL1 (encoding nuclear factor of
kappa light polypeptide gene enhancer in B-cells
inhibitor-like 1), LTA, TNF, LTB, LST1 (encoding leuco-
cyte specific transcript 1) and NCR3 (encoding natural
cytotoxicity triggering receptor 3). The 3C assay was
developed in which unstimulated or mitogen-induced
Jurkat T cells were treated with formaldehyde to cross-
link protein–DNA and protein–protein interactions;
restriction enzyme digested, diluted and ligated such
that intramolecular ligations between crosslinked frag-
ments are favoured over intermolecular ligation between
random DNA fragments. Quantitative PCR using Taq-
Man technology was performed to analyse the ligation
products generated by 3C,
25 including a PCR control
template of a restriction enzyme digested and ligated
BAC clone spanning the TNF locus. This showed
evidence of interaction between LTB exon 4 and the
LTB promoter, the LTA promoter and TNF 30UTR
(Figure 4). This was reproducibly seen for three
biological replicate experiments and across different
time points of stimulation, although was most striking
in the unstimulated state. In HeLa cells, which express
LTB at very low levels,
5 there was evidence of interaction
with the LTB promoter but not at other sites (Figure 4).
CTCF binding at LTB exon 4
Our findings of accessible chromatin, histone acetylation,
recruitment of YY1 and DNA looping interactions across
the TNF locus led us to hypothesise that CTCF may be
involved. CTCF is an 11 zinc-finger protein with diverse
roles in transcriptional regulation, notably not only as an
insulator element but also involved in transcriptional
repression and activation.
26,27 There is flexibility in
the precise DNA-binding motifs recognised by CTCF
but recent genome-wide analyses of CTCF-binding
sites have defined a 20-mer motif.
28 We analysed the
DNA sequence spanning exon 4 of LTB, using the
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Figure 3 Protein–DNA interactions in LTB1 footprinted region. (a) EMSA using a radiolabelled probe spanning the footprinted region run
without (lane 1) or with nuclear extracts from Jurkat T cells either unstimulated (J) (lane 2) or following stimulation with PMA and
ionomycin for 2h (K) (lane 3) or 6h ( ) (lane 4–14). Binding in the presence of molar excess of unlabelled competitor probe is shown (lanes
5–10) and specific antibodies as indicated (lanes 12–14). (b) ChIP experiments using antibodies to CREB and YY1 for Jurkat T cells, either
resting or collected at 2h after induction with PMA and ionomycin. Immunoprecipitated DNA was analysed using quantitative real-time
PCR using seven amplicons to interrogate the region spanning LTB. On the y axis, the mean fold difference (±s.e.m.) in enrichment of each of
the PCR amplicons is expressed relative to input DNA for three ChIP experiments. Genomic location is shown on the x axis.
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Genes and ImmunityCTCF-binding site database.
29 This showed a high-
position weight matrix score of 16.7 (greater than 3.0 is
a suggestive match), and the sequence, which includes
DNase I footprint LTB2, was a match for the CTCF
consensus motif (Figure 5). We proceeded to investigate
further the potential binding by CTCF to this site in LTB
exon 4 by EMSA using nuclear extracts from Jurkat T
cells. This showed evidence of constitutive binding by
specific complexes on competition EMSA, which were
competed by unlabelled probes corresponding to a
known CTCF-binding site in the chicken b-globin gene
insulator (HS4),
30 but not by the same probe containing
specific point mutations disrupting the CTCF-binding
site (Figure 5). We then investigated whether CTCF
was binding in vivo by chromatin immunoprecipitation.
These experiments showed evidence of constitutive
CTCF binding to this region in Jurkat T cells (Figure 5).
We analysed a number of different data sets mapping
CTCF binding across the human genome.
28,31,32 This
provided robust evidence of CTCF binding in LTB exon
4, across a range of cell types, including primary CD4þ
Tcells (Supplementary Figure S1). Looking more broadly
across a 60-kb window that includes LTB, we noted two
other CTCF-binding sites in regions flanking the TNF
locus, located at NFKBIL1 and LST1.
Evidence of transcriptional repression
The complex protein–DNA interactions involving CTCF
suggest this site may be functioning as a boundary
element, insulating LTB from the activity of the neigh-
bouring TNF and LTA genes; or modulating gene
expression through DNA looping, as suggested by the
3C experiments. We therefore engineered reporter gene
constructs in which sequences corresponding to the
region were placed downstream of the luciferase gene in
a pGL3 reporter construct, driven by the SV40 promoter.
Transient transfection experiments using a construct
containing a 1kb sequence spanning LTB exon 4 showed
significant repression of transcriptional activity, by 3.3-
fold (95% confidence intervals 1.7–4.9) in resting cells
and by 5.4-fold (4.0–6.7) following mitogen stimulation
(Figure 6). This effect was reduced by 50% when a
shorter sequence, spanning the CTCF site but not the
YY1 or CREB-binding sites, was inserted downstream of
the luciferase gene in pGL3-SV40Prom.
A functional role for YY1 and CREB in LTB gene expression
We specifically investigated the effects of knockdown of
YY1 and CREB for LTB expression by transient transfec-
tion of Jurkat T cells using small-interfering RNAs
(siRNAs). At the mRNA level there was efficient knock-
down of YY1 and CREB at 72h after transfection,
whereas a cocktail of non-targeting control siRNAs had
no effect (Figure 7). Significant suppression of LTB
expression was observed only when both YY1 and CREB
were knocked down (Figure 7).
Discussion
The TNF locus within the MHC class III region encodes
three important members of the TNF superfamily whose
expression is tightly regulated at the transcriptional
level. For LTB, attention has focused on the role of
proximal promoter elements, notably NFkB, Ets and
Egr-1.
7,8,18 Our data suggests an additional layer of
complexity involving sequences in the fourth exon of
LTB. We note that this region contains the only signifi-
cant CpG island in the TNF locus, and is associated
with histone modifications and an open chromatin
configuration based on DNase hypersensitivity map-
ping. We find evidence of a novel regulatory element
in this region, which involves CTCF binding together
with YY1 and CREB, and is associated with multiple
sites of interaction across the TNF gene cluster,
notably with the LTA and LTB promoter regions, and
TNF 30 UTR.
Further work is needed to investigate more fully the
functional implications of these interactions, but the
evidence of DNA looping may prove highly significant.
Coordinate expression of LTa and LTb is important, both
during development and induction of the adaptive
immune response. These proteins bind to the LTb
receptor as a heterodimer,
33 regulating diverse processes
ranging from secondary lymphoid organogenesis to
T-cell differentiation, with dysregulation important in
immunity and other disease processes.
12–14
Our finding of transcriptional repressor activity on
reporter gene analysis for a region associated with CTCF
binding is consistent with the original isolation and
cloning of this protein at the chicken and human c-myc
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Figure 4 3C assays show sites of interactions across the TNF locus
with LTB exon 4. Relative crosslinking frequencies are shown for
different ligation products quantified using a constant primer
and TaqMan probe in LTB exon 4 and primers tiled over the TNF
gene locus (chr6: 31621496–31669390) shown by arrowheads and
shaded vertical bars. Vertical arrows denote the location of
restriction enzyme sites for DpnII. The mean±s.e.m. is shown for
three biological replicate experiments using HeLa cells or Jurkat T
cells, either unstimulated or induced with PMA/ionomycin.
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Genes and Immunityoncogene,
34,35 although it rapidly became clear that the
effects of CTCF were pleiotropic. This includes transcrip-
tional activation, enhancer blocking activity and more
recently an appreciation of the key role of CTCF in intra-
and inter-chromosomal looping.
26,27 The latter can have
remarkably complex and specific functions, notably at
imprinted gene loci such as H19/Igf2, which are critical to
allele-specific expression, insulator activity and main-
tenance of specific DNA-methylation patterns.
36,37
Indeed, it is now thought that the primary role of CTCF
is related to chromatin architecture, functioning as the
‘master weaver of the genome’,
27 critical to regulation of
gene expression.
The presence of a YY1-binding site within 250bp of
the CTCF-binding element at LTB is potentially highly
significant, given the known role of YY1 as a cofactor
interacting with CTCF, involved for example in X-
chromosome inactivation.
26,38 YY1, like CTCF, is a zinc
finger protein involved in diverse biological processes,
including transcriptional repression, as seen for example
through recruitment of polycomb group proteins leading
to methylation of histone H3 K27.
39 There is evidence of
direct interaction between YY1 and the N-terminus
of CTCF with paired CTCF/YY1 sites noted in the
X-inactivation centre, and evidence of a synergistic and
essential role for CTCF and YY1 in transactivation of
Tsix.
38 Both YY1 and CTCF have critical roles at
imprinting control regions characterised by differentially
methylated CpG islands, and tandem arrays of CTCF- or
YY1-binding sites, for example, at H19/Igf2 and Peg3.
40
Although none of the genes in the TNF locus are
imprinted, there is evidence of allele-specific expres-
sion
41 and epigenetic regulation is important.
42 It will be
interesting to see in future work whether allele-specific
differences relate to CTCF and YY1 binding in the final
exon of the LTB gene.
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Figure 5 CTCF binding at LTB exon 4. (a) Human (hg18 chr6: 31656745–31656774) and mouse (mm9 chr17: 35332794–35332823) sequence
alignment in LTB exon 4 at site of putative CTCF-binding site aligned to consensus sequence logo.
28 (b) EMSA investigating protein–DNA
interactions using a radiolabelled probe spanning the putative CTCF binding site in LTB alone (lanes 1) or incubated with nuclear extracts
from Jurkat Tcells either unstimulated (J) (lane 2) or following stimulation with PMA and ionomycin for 2h (K) (lane 3) or 6h ( ) (lanes 4–
10). The results of competition using molar excess of unlabelled competitor probe corresponding to the LTB exon 4 sequence is shown (lanes
5–6), together with data relating to a probe corresponding to the chicken beta globin insulator HS4 (lane 7) or the same HS4 probe with key
CTCF-binding residues mutated (HS4D) (lane 8). The effect of specific antibodies is also shown (lanes 9–10). (c) ChIP experiments using
antibodies to CTCF are shown for Jurkat T cells, either resting or collected at 2h after induction with PMA and ionomycin. The
immunoprecipitated DNA was analysed using quantitative real-time PCR using seven primer pairs to interrogate the region spanning LTB
(chr6: 31655630–31660002). The mean fold difference (±s.e.m.) in enrichment of each of the PCR amplicons is expressed relative to input
DNA for three ChIP experiments.
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Figure 6 Effects of LTB exon 4 sequences on reporter gene expression in Jurkat T cells. (a) Reporter gene design. (b) Jurkat cells were
transiently transfected with different pGL3 reporter constructs as indicated, either pGL3 basic, pGL3 driven by SV40 promoter alone or in the
presence of sequence spanning the YY1/CREB/CTCF sites (ch6:31656365–31657327) or the CTCF-binding site without the YY1/CREB-
binding sites (chr6: 31656631–31656999). The mean±s.e.m. of luciferase expression values are shown (normalised by pRL-TK) for five
independent transfection experiments, each performed in duplicate. Open bars show expression for unstimulated cells, black bars values
following mitogen stimulation (PMA/ionomycin). *Po0.0001, **P¼0.03, ***P¼0.02 on paired t-test (two tailed).
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Genes and ImmunityWe also note the evidence of CREB binding in this
region of LTB. YY1 and CREB have been shown to be
involved in the activation and repression of gene
expression in many different genes, both alone and in
some cases together as noted at c-fos.
43,44 siRNA experi-
ments demonstrate a functional role for YY1 and CREB
in LTB gene expression, with reduced expression of LTB
when these transcription factors are knocked down.
However, further work is required to define whether
there are additional YY1- and CREB-binding sites
important in the regulation of LTB or whether the effect
is directly mediated by the binding sites in the fourth
exon of LTB. Given the complex interactions involving
CTCF at this site, it is also difficult to establish the
functional consequences of YY1 and CREB binding when
they are studied in isolation. The binding sites are within
a region showing striking evidence of histone acetylation
and the recruitment of chromatin remodelling activity
associated with CREB binding protein and p300 by both
YY1 and CREB might prove important but further work
is required to characterise this.
45–47
In summary, we have characterised a novel regulatory
element in the final exon of LTB, which involves complex
protein–DNA interactions, with recruitment of YY1,
CREB and CTCF. We find evidence of transcriptional
repression and DNA looping whereby this region
interacts with other sites in the TNF locus, notably the
LTA promoter, LTB promoter and TNF 30 UTR, high-
lighting the complexities of transcriptional regulation in
this locus and the previously unrecognised role of CTCF.
Materials and methods
Cell culture
Jurkat T cells were grown in RPMI 1640 (Sigma-Aldrich,
Dorset, UK) supplemented with 2mM glutamine (Sigma),
100Uml
 1 penicillin (Sigma), 0.1mgml
 1 streptomycin
(Sigma) and 10% fetal calf serum (Sigma) at 371Ci n
5% CO2 and collected in mid-log phase. Mitogens used
for cell stimulation were 125nM ionomycin (Sigma) and
200nM PMA (Sigma) (final concentration).
Nuclear extracts, electrophoretic mobility shift assays
Nuclear extracts were prepared from Jurkat T cells as
previously described.
48 Oligonucleotide probes were
radiolabelled with
32P dCTP (Perkin-Elmer, Beaconsfield,
UK) and EMSA performed as previously described.
49 For
supershift analysis, antibodies to YY1 (sc1703) (Santa
Cruz Biotechnology, Santa Cruz, CA, USA), CREB (sc-
186), HSF1 (sc9144), and CTCF (07–729) (Millipore,
Billerica, MA, USA) were used. Probes were generated
by annealing forward and reverse oligonucleotides. The
sequences are shown in the Supplementary Table; the
sequences for CTCF HS4 and HS4D (see ref. 30) are as
previously reported.
Solid-phase DNase I footprinting
This was performed as previously described.
5 Three
radiolabelled DNA probes designed to tile across LTB
exon 4 were generated by PCR using one biotinylated
primer and one primer end labelled with g32P by T4
polynucleotide kinase. Genomic DNA from the PGF cell
line was used for PCR amplification; PGF provides the
reference sequence for human genome and is homo-
zygous over the MHC.
50 The sequences are shown in the
Supplementary Table. Radiolabelled DNA probe ad-
sorbed onto magnetic Dynabeads M-280 Streptavidin
(Invitrogen, Paisley, UK) was incubated in a binding
reaction alone (naked DNA) or with nuclear extract
from Jurkat T cells. Following DNase I digestion, DNA-
binding reactions were analysed on a 7% acrylamide
urea gel (7 M) and areas of protection localised using a
Maxam-Gilbert sequencing ladder.
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Figure 7 Silencing of YY1 and CREB suppresses expression of LTB.
Jurkat T cells were transfected with a pool of siRNAs targeting the
30UTR and open reading frame of YY1, CREB, YY1 and CREB,o ra
cocktail of non-targeting control siRNAs, and collected after 72h.
Expression of endogenous (a) YY1 (b) CREB (c) LTB was quantified
in duplicate by quantitative real-time PCR. The mean±s.e.m. of
three biological replicate experiments is shown with each experi-
ment comprising two transfections. *Po0.05, **Po0.01 on unpaired
t-test (two tailed).
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For a given assay, 1 10
8 Jurkat T cells were crosslinked
with formaldehyde and chromatin isolated, sonicated
and immunoprecipitated as previously described.
5 Sheep
anti-rabbit IgG coated Dynabeads, preincubated with
specific primary antibodies, were used for immuno-
precipitation. For quantitative chromatin immunopreci-
pitation analysis by real-time PCR, we followed the
methodology described by De Gobbi
51 with the amount
of DNA immunoprecipitated by a specific antibody
quantified relative to that of non-immunoprecipitated
(input) DNA, and normalised relative to a control
sequence in the 18S ribosomal RNA gene.
Quantitative chromatin conformation capture (3C-qPCR)
assay
3C-qPCR was performed as previously described
25
with minor modifications. Briefly, 1 10
7 Jurkat T cells
or HeLa cells were collected for a given condition, cross-
linked for 10min using 2% formaldehyde and lysed
using ice-cold lysis buffer (10mM Tris pH 8, 10mM NaCl,
0.2% NP-40, 1  complete protease inhibitor (Roche,
Burgess Hill, UK)) and nuclei resuspended in restriction
enzyme buffer, incubated at 371C with SDS (0.3% final)
for 1h then Triton-X 100 (2% final) for 1h before
restriction enzyme digestion with 400U DpnII (NEB,
Hitchin, Hertfordshire, UK) overnight at 371C. Samples
were then incubated with SDS (1.3% final) for 20min at
651C, placed in ligation buffer with Triton-X 100 (Roche)
(1% final) for 1h at 371C before ligation using high-
concentration T4 ligase (Fermentas UK, York, UK) at
161C for 4h followed by 30min at room temperature.
Samples were digested with proteinase K (Roche) and
incubated at 651C overnight to reverse crosslinks and
digest the proteins. Following RNase digestion and
phenol–chloroform extraction, DNA was precipitated
and resuspended in water. DNA concentration was
determined using SybrGreen quantitative PCR and a
reference sample of genomic DNA with an internal
primer set that did not span a restriction site, and
volumes adjusted to normalise concentrations across
samples. TaqMan real-time PCR quantification for 3C
samples was determined including standard curves of
serially diluted control template for each primer set to
normalise amplification efficiency. For this BAC RP11-
184 (chr6: 31545955–31736849) (BAC PAC Resources,
Children’s Hospital Oakland Research Institute) was
used after digestion with Sau3A1 (isoschizomer of
DpnII), ligation and purification. The probe and primer
sequences are shown in the Supplementary Table.
Reporter gene assays
DNA fragments spanning LTB exon 4 were synthesised
by PCR amplification of genomic DNA from the PGF cell
line. PCR primer design introduced restriction sites to
clone into BamHI/SalI sites downstream of the luciferase
gene in the pGL3prom vector (Promega, Madison, WI,
USA): for pGL3-LTB-SV40prom, Forward 50-AGCTGG
ATCCTCAATTTCCAAACAGTCTCCTACA-30, Reverse
50-TCGAGTCGACGCCCACCTCATAGGTAAGGA-30
(chr6: 31656365-31657327); for pGL3-LTB1-SV40prom,
Forward 50-AGCTGGATCCAGCACTGGAGTCACCGT
CTC-30, Reverse 50-TCGAGTCGACGCTAAAAGCCGC
CACTTCC-30 (chr6: 31656631-31656999). All constructs
were verified by sequencing. Jurkat T cells were
transiently transfected using Lipofectamine LTX and
PLUS reagent (Invitrogen) according to the manufac-
turer’s instructions, allowed to recover after transfection
for 1h, then in which indicated were stimulated with
PMA and ionomycin. Cells were collected after 24h and
luciferase assays performed following the manufac-
turer’s protocol. Firefly luciferase constructs were co-
transfected with pRL-TK (Promega) to allow normal-
isation of transfection efficiencies. Two independent
endotoxin-free preparations of all constructs were
analysed in transfection experiments.
siRNA knockdown assay
siRNA knockdown was performed according to the
manufacturer’s instructions using Accell SMARTpool
siRNA duplexes (Dharmacon, Lafayette, CO, USA)
targeting the 30UTR and open reading frame of YY1,
CREB, YY1 and CREB, or a cocktail of non-targeting
control siRNAs. Briefly, 2 10
4 cells/well were resus-
pended in Accell delivery media (Dharmacon) and
incubated with 1mM of each siRNA duplex for 72h. Each
transfection was carried out in duplicate for three
replicate experiments. Total RNA was collected for each
sample using an RNeasy mini kit (QIAGEN, Crawley,
W Sussex, UK) including an on-column genomic DNA
digestion step and cDNA prepared using a Superscript
III kit (Invitrogen) primed with random hexamers.
Expression of endogenous (1) YY1 (2) CREB (3) LTB
was quantified in duplicate by SybrGreen quantitative
real-time PCR using transcript-specific primers.
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